I’ve worked in hospitals for years and believe that clinicians come up with lots of innovative ways to do things better. The stumbling block is getting them to come to fruition. I was looking for people to help me out, struggling, thinking this is never going to happen. CPI listened, they got it, and they’ve made it a reality.

CPI accelerated our route to commercialisation by a long way, all of the work was done in CPI with access to scientists and equipment. This saved us in the region of £750K — £1m capital investment.

CPI designed the electronics that enabled us to repackage our technology into a wearable and portable form. The collaboration has also enabled us to rigorously test all the components to meet safety standards. We can now bring this technology to more people to help with their stroke rehabilitation.

It has been a fantastic experience working alongside CPI. For every obstacle that we’ve come across, the CPI team have been prepared to investigate and find ways around them. Although we've only made early progress along a much longer road to commercialisation, I feel confident that this road has been roughly mapped out by the knowledge and contacts provided by CPI.

CPI has played a pivotal role in the development of ENHALE, allowing us to identify the optimum materials and processes for the scalable & sustainable manufacturer of a safe and efficacious medicine.